AH, K., DF, W., LL, G., CE, P., LS, W., RM, B., . . . J, S. (1996). Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha. British journal of pharmacology, 117(6), 1171. https://doi.org/10.1111/j.1476-5381.1996.tb16712.x
Chicago Style (17th ed.) CitationAH, Krauss, et al. "Evidence for Human Thromboxane Receptor Heterogeneity Using a Novel Series of 9,11-cyclic Carbonate Derivatives of Prostaglandin F2 Alpha." British Journal of Pharmacology 117, no. 6 (1996): 1171. https://doi.org/10.1111/j.1476-5381.1996.tb16712.x.
MLA (9th ed.) CitationAH, Krauss, et al. "Evidence for Human Thromboxane Receptor Heterogeneity Using a Novel Series of 9,11-cyclic Carbonate Derivatives of Prostaglandin F2 Alpha." British Journal of Pharmacology, vol. 117, no. 6, 1996, p. 1171, https://doi.org/10.1111/j.1476-5381.1996.tb16712.x.